Search details
1.
Development of an agar-based screening method for terbinafine, itraconazole, and amorolfine susceptibility testing of Trichophyton spp.
J Clin Microbiol
; 62(1): e0130823, 2024 01 17.
Article
in English
| MEDLINE | ID: mdl-38117081
2.
Evaluation of the Vitek 2 system for antifungal susceptibility testing of Candida auris using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance.
J Clin Microbiol
; 62(4): e0152823, 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38501836
3.
Optimization of the EUCAST reference broth microdilution method for echinocandin susceptibility testing of Aspergillus fumigatus.
J Antimicrob Chemother
; 78(12): 2830-2839, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37811550
4.
Can bronchial secretion cultures identify the etiologic agent of COVID-19-associated pulmonary aspergillosis in ICU patients? Comparison with a species-specific Aspergillus PCR in serum.
Med Mycol
; 61(1)2022 Dec 29.
Article
in English
| MEDLINE | ID: mdl-36477291
5.
A fatal neonatal case of fungemia due to Exophiala dermatitidis-case report and literature review.
BMC Pediatr
; 22(1): 482, 2022 08 10.
Article
in English
| MEDLINE | ID: mdl-35948953
6.
Filamentous Fungal Keratitis in Greece: A 16-Year Nationwide Multicenter Survey.
Mycopathologia
; 187(5-6): 439-453, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36178544
7.
Comparative Pharmacodynamics of Echinocandins against Aspergillus fumigatus Using an In Vitro Pharmacokinetic/Pharmacodynamic Model That Correlates with Clinical Response to Caspofungin Therapy: Is There a Place for Dose Optimization?
Antimicrob Agents Chemother
; 65(4)2021 03 18.
Article
in English
| MEDLINE | ID: mdl-33495222
8.
Population pharmacokinetics of anidulafungin in ICU patients assessing inter- and intrasubject variability.
Br J Clin Pharmacol
; 87(3): 1024-1032, 2021 03.
Article
in English
| MEDLINE | ID: mdl-32633039
9.
Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Article
in English
| MEDLINE | ID: mdl-31871083
10.
Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated In Vitro Pharmacokinetic/Pharmacodynamic Model.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Article
in English
| MEDLINE | ID: mdl-32229492
11.
A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method.
J Antimicrob Chemother
; 75(7): 1799-1806, 2020 07 01.
Article
in English
| MEDLINE | ID: mdl-32330938
12.
Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
J Antimicrob Chemother
; 75(11): 3181-3188, 2020 11 01.
Article
in English
| MEDLINE | ID: mdl-32814940
13.
Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
J Antimicrob Chemother
; 75(1): 140-148, 2020 01 01.
Article
in English
| MEDLINE | ID: mdl-31665417
14.
Comparative pharmacokinetics of the three echinocandins in ICU patients.
J Antimicrob Chemother
; 75(10): 2969-2976, 2020 10 01.
Article
in English
| MEDLINE | ID: mdl-32696036
15.
Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources.
Mycoses
; 63(1): 78-88, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31609022
16.
In Vitro and In Vivo Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatus.
Antimicrob Agents Chemother
; 63(6)2019 06.
Article
in English
| MEDLINE | ID: mdl-30962332
17.
Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.
J Antimicrob Chemother
; 74(8): 2247-2254, 2019 08 01.
Article
in English
| MEDLINE | ID: mdl-31106352
18.
A New Marker of Echinocandin Activity in an In Vitro Pharmacokinetic/Pharmacodynamic Model Correlates with an Animal Model of Aspergillus fumigatus Infection.
Antimicrob Agents Chemother
; 62(5)2018 05.
Article
in English
| MEDLINE | ID: mdl-29463527
19.
Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.
J Clin Microbiol
; 55(6): 1714-1719, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28330883
20.
Bioassay for Determining Voriconazole Serum Levels in Patients Receiving Combination Therapy with Echinocandins.
Antimicrob Agents Chemother
; 60(1): 632-6, 2016 01.
Article
in English
| MEDLINE | ID: mdl-26503649